Clinical Trials Browser

Phase 2 × Antimetabolites × Other hematologic neoplasm × Clear all

NCT01960387 2016-08-02

UPCI 13-066

Phase 2 Terminated

2 enrolled 6 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute